Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLaw Debenture Regulatory News (LWDB)

Share Price Information for Law Debenture (LWDB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 844.00
Bid: 845.00
Ask: 847.00
Change: -6.00 (-0.71%)
Spread: 2.00 (0.237%)
Open: 844.00
High: 847.00
Low: 844.00
Prev. Close: 850.00
LWDB Live PriceLast checked at -
Law Debenture Corporation is an Investment Trust

To achieve long term capital growth in real terms and steadily increasing income through investing in a diverse portfolio of investments spread both geographically and by sector.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dividend Declaration

29 Sep 2022 14:22

RNS Number : 2134B
Law Debenture Corp PLC
29 September 2022
 

The Law Debenture Corporation p.l.c.

Second Interim Dividend Announcement

· Declaring a second interim dividend of 7.25 pence per ordinary share payable in October 2022, representing an increase of 5.5% over the prior year's second interim dividend.

· It is the Board's intention for each of the first three interim dividends for 2022 to be equivalent to a quarter of Law Debenture's total 2021 dividend of 29.0 pence per ordinary share.

 

The combination of IPS' steady income and our strong reserves allows Law Debenture to continue its 44-year track record of maintaining or increasing its dividend payments.

This dividend will be paid on 27 October 2022 to shareholders on the register at close of business on 7 October 2022. The Corporation's shares will go ex-dividend on 6 October 2022. 

Law Debenture Corporate Services Limited

Corporate Secretary

29 September 2022

 

Contact:

Tulchan Communications

David Allchurch, Deborah Roney

Lawdebenture@tulchangroup.com

+44 (0)777 193 7173

 

Notes to Editor

Law Debenture's equity portfolio of investments is managed by James Henderson and Laura Foll of Janus Henderson Investors.

Our objective is to achieve long-term capital growth in real terms and steadily increasing income. The aim is to achieve a higher rate of total return than the FTSE Actuaries All-Share Index Total Return through investing in a diversified portfolio of stocks.

In the last ten years Law Debenture has increased its dividend by more than 100% and outperformed its benchmark and the FTSE Actuaries All-Share Index by 126.3%1.

Our leading independent professional services business accounts for 18% of Law Debenture's NAV but has funded 36% of dividends over the past decade. As a result, our Investment Managers' have the flexibility of selecting strong business models and attractive valuation opportunities, which will continue to position the equity portfolio for future longer-term growth and outperformance.

The Law Debenture Corporation p.l.c. is registered in England, company registration number 00030397. LEI number - 2138006E39QX7XV6PP21

1 Source: Law Debenture's Annual Financial Report for the period ended 31 December 2021.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVPPUGPBUPPGWB
Date   Source Headline
12th Jan 20235:10 pmRNSIssue of Equity
12th Jan 20234:28 pmRNSNet Asset Value(s)
11th Jan 20233:03 pmRNSNet Asset Value(s)
10th Jan 20234:54 pmRNSNet Asset Value(s)
9th Jan 20234:39 pmRNSNet Asset Value(s)
6th Jan 20233:35 pmRNSNet Asset Value(s)
5th Jan 20234:49 pmRNSIssue of Equity
5th Jan 20233:47 pmRNSNet Asset Value(s)
4th Jan 20233:24 pmRNSNet Asset Value(s)
3rd Jan 20234:34 pmRNSNet Asset Value(s)
3rd Jan 20237:00 amRNSBlock listing Interim Review
3rd Jan 20237:00 amRNSTotal Voting Rights
3rd Jan 20237:00 amRNSNet Asset Value(s)
29th Dec 20224:28 pmRNSDirector/PDMR Shareholding
29th Dec 20224:27 pmRNSNet Asset Value(s)
28th Dec 20223:51 pmRNSDirector/PDMR Shareholding
28th Dec 20222:11 pmRNSNet Asset Value(s)
28th Dec 20227:00 amRNSNet Asset Value(s)
22nd Dec 20224:30 pmRNSIssue of Equity
22nd Dec 202211:43 amRNSNet Asset Value(s)
21st Dec 20224:42 pmRNSIssue of Equity
21st Dec 20222:48 pmRNSNet Asset Value(s)
20th Dec 202212:53 pmRNSNet Asset Value(s)
19th Dec 20225:24 pmRNSIssue of Equity
19th Dec 20222:44 pmRNSNet Asset Value(s)
16th Dec 20224:01 pmRNSNet Asset Value(s)
15th Dec 20224:19 pmRNSNet Asset Value(s)
15th Dec 20223:36 pmRNSDividend Declaration
14th Dec 20222:30 pmRNSNet Asset Value(s)
13th Dec 20224:53 pmRNSIssue of Equity
13th Dec 20223:38 pmRNSNet Asset Value(s)
12th Dec 20224:11 pmRNSNet Asset Value(s)
9th Dec 20223:21 pmRNSNet Asset Value(s)
8th Dec 202212:42 pmRNSNet Asset Value(s)
7th Dec 20223:51 pmRNSNet Asset Value(s)
6th Dec 20223:29 pmRNSNet Asset Value(s)
5th Dec 20223:16 pmRNSNet Asset Value(s)
2nd Dec 20224:31 pmRNSIssue of Equity
2nd Dec 20224:26 pmRNSNet Asset Value(s)
1st Dec 20224:10 pmRNSNet Asset Value(s)
1st Dec 20223:24 pmRNSTotal Voting Rights
30th Nov 20224:42 pmRNSNet Asset Value(s)
29th Nov 20224:04 pmRNSNet Asset Value(s)
28th Nov 202211:54 amRNSNet Asset Value(s)
28th Nov 202211:52 amRNSDirector Declaration
25th Nov 20225:33 pmRNSNet Asset Value(s)
24th Nov 20225:29 pmRNSNet Asset Value(s)
24th Nov 20224:54 pmRNSIssue of Equity
23rd Nov 20224:59 pmRNSIssue of Equity
23rd Nov 20223:54 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.